News
Gilead Sciences to acquire ADC developer Immunomedics for $21bn
Gilead Sciences, Inc. and Immunomedics announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for $88.00 per...
News
Oxford University resume Covid-19 vaccine trial
Oxford University on Saturday, 13th Sep. 2020 announced resuming coronavirus vaccine trials, the study which was suspended following a reported side-effect in a UK patient....
News
DCGI nod to Serum-Oxford covid-19 vaccine for phase 2,...
India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and 3...
News
Serum Institute of India COVID-19 Vaccine advances to trial...
Serum institute has completed phase II-B3 trails and will commence phase-III trail after clearances. The third phase trail will be tested on 1500 patients at...
News
Paradigm4 launches Revels Single Cell app for analysing large-scale...
Paradigm4, specialist in scientific data management and scalable computation, has launched its REVEAL: Single CellTM app to offer biopharmaceutical developers the ability to break through...
News
Lubrizol Life Science Health awarded grant for generic contraceptive...
The Lubrizol Corporation has announced that the contract development and manufacturing organization (CDMO) of Lubrizol Life Science Health (LLS Health) has been awarded a grant...
News
Botanical Solution Inc. (BSI) Appoints Marcus Meadows-Smith to their...
Botanical Solution Inc. (BSI), an innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials (ABM), has appointed Marcus Meadows-Smith to its Board of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.